Paper12475151
Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
Su WJ and 1 other. Int J Tuberc Lung Dis, 2002. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up. Papers, record 12475151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12475151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Isoniazid | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Pyrazinamide | Major topic |
| Rifampin | Major topic |
| Tuberculosis, Pulmonary | Major topic |
| Adult | |
| Drug Combinations | |
| Female | |
| Humans | |
| Male | |
| Patient Compliance | |
| Sputum | |
| Taiwan |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38500521 | Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes. | J Health Econ Outcomes Res | 2024 | https://conductscience.org/library/papers/38500521 | PubMed |
| 32476718 | Health technology assessment of fixed-dose combination regimen in treatment of newly diagnosed smear-positive pulmonary tuberculosis: A meta-analysis. | Med J Armed Forces India | 2020 | https://conductscience.org/library/papers/32476718 | PubMed |
| 30089476 | Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar. | BMC Infect Dis | 2018 | https://conductscience.org/library/papers/30089476 | PubMed |
| 28063922 | Efficacy and safety of a four-drug fixed-dose combination regimen versus separate drugs for treatment of pulmonary tuberculosis: a systematic review and meta-analysis. | Braz J Microbiol | 2017 | https://conductscience.org/library/papers/28063922 | PubMed |
| 27322164 | Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial. | PLoS One | 2016 | https://conductscience.org/library/papers/27322164 | PubMed |
| 27186634 | Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27186634 | PubMed |
| 26106962 | Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment. | Clinics (Sao Paulo) | 2015 | https://conductscience.org/library/papers/26106962 | PubMed |
| 26056374 | Intermittent Versus Daily Pulmonary Tuberculosis Treatment Regimens: A Meta-Analysis. | Clin Med Res | 2015 | https://conductscience.org/library/papers/26056374 | PubMed |
| 25879615 | Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study. | BMC Infect Dis | 2015 | https://conductscience.org/library/papers/25879615 | PubMed |
| 25276422 | The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-Analysis. | AIDS Res Treat | 2014 | https://conductscience.org/library/papers/25276422 | PubMed |
| 19753109 | Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. | PLoS Med | 2009 | https://conductscience.org/library/papers/19753109 | PubMed |
| 19475775 | Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives. | Vasc Health Risk Manag | 2009 | https://conductscience.org/library/papers/19475775 | PubMed |
| 17519122 | Compliance and fixed-dose combination therapy. | Curr Hypertens Rep | 2007 | https://conductscience.org/library/papers/17519122 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12475151
GET https://conductscience.org/api/papers/v1/12475151/authors